Assessing specificity of indazole derivatives as inhibitors to CYP2E1

被引：0
|
作者：
Hart, Hannah [1 ]
Miller, Grover [2 ]
机构：
[1] Ouachita Baptist Univ, Dept Chem, Arkadelphia, AR USA
[2] Dept Biochem & Mol Biol, Little Rock, AR USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2017年 / 253卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
1188
引用
收藏
页数：1
相关论文
共 50 条
  • [41] CYP2E1 activity is not altered by influenza vaccination
    Kim, RB
    Wilkinson, GR
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (04) : 529 - 530
  • [42] The Impact of CYP1A2 and CYP2E1 Genes Polymorphism on Theophylline Response
    Sutrisna, E. M.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (11) : FE1 - FE3
  • [43] Toxicological implications of mitochondrial localization of CYP2E1
    Hartman, Jessica H.
    Miller, Grover P.
    Meyer, Joel N.
    TOXICOLOGY RESEARCH, 2017, 6 (03) : 273 - 289
  • [44] Role of CYP1A2 and CYP2E1 in the pentoxifylline ciprofloxacin drug interaction
    Peterson, TC
    Peterson, MR
    Wornell, PA
    Blanchard, MG
    Gonzalez, FJ
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (02) : 395 - 402
  • [45] Novel CYP2E1 dependent farnesol ω-hydroxylation
    DeBarber, AE
    Bleyle, LA
    Roullet, JBO
    Koop, DR
    FASEB JOURNAL, 2003, 17 (05): : A1318 - A1318
  • [46] CHLORZOXAZONE IS METABOLIZED BY HUMAN CYP1A2 AS WELL AS BY HUMAN CYP2E1
    ONO, S
    HATANAKA, T
    HOTTA, H
    TSUTSUI, M
    SATOH, T
    GONZALEZ, FJ
    PHARMACOGENETICS, 1995, 5 (03): : 143 - 150
  • [47] Chemical characteristics for optimizing CYP2E1 inhibition
    van de Wier, B.
    Balk, J. M.
    Bast, A.
    Koek, G. H.
    Haenen, G. R. M. M.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2015, 242 : 139 - 144
  • [48] CYP2E1 polymorphism and susceptibility to cervical cancer
    Costa, M.
    Ferreira, P.
    Catarino, R.
    Pereira, D.
    Matos, A.
    Coelho, A.
    Lopes, C.
    Medeiros, R.
    EJC SUPPLEMENTS, 2005, 3 (02): : 279 - 279
  • [49] Transcriptional regulation of CYP2E1 by dexamethasone.
    Hafner, MS
    Novak, RF
    FASEB JOURNAL, 2000, 14 (08): : A1333 - A1333
  • [50] CYP2E1 and risk of chemically mediated cancers
    Trafalis, Dimitrios T.
    Panteli, Eleftheria S.
    Grivas, Anastasios
    Tsigris, Christos
    Karamanakos, Petros N.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (03) : 307 - 319
12345